Advisory Committee on Heritable Disorders in Newborns and Children, 5265 [2018-02306]

Download as PDF Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC immunization schedules must be covered by applicable health plans. Matters To Be Considered: The agenda will include discussions on Influenza vaccines, evidence based recommendations, anthrax vaccine, Japanese encephalitis vaccines, hepatitis vaccines, human papillomavirus vaccines, pneumococcal vaccines, meningococcal disease, and an update on vaccines and other biologics for prevention and treatment of healthcareassociated infections. A recommendation vote is scheduled for hepatitis vaccines and evidence based recommendations. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–02268 Filed 2–5–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration Advisory Committee on Heritable Disorders in Newborns and Children Health Resources and Service Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice; correction. daltland on DSKBBV9HB2PROD with NOTICES AGENCY: This notice announces a correction to the meeting announcement for a public meeting of the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC), published in the Federal Register on January 22, 2018. The meeting has changed from a two-day meeting to a SUMMARY: VerDate Sep<11>2014 19:02 Feb 05, 2018 Jkt 244001 one-day meeting, to be held on Thursday, February 8, 2018. Agenda items have been updated and will include a final evidence-based review report on the spinal muscular atrophy (SMA) condition nomination for possible inclusion on the Recommended Uniform Screening Panel (RUSP). Following this report, the ACHDNC expects to vote on whether to recommend adding SMA to the RUSP to the Secretary of HHS. The agenda will also include presentation of a document on cutoff determinations and risk assessment methods used for dried bloodspot newborn screening. The Committee expects to vote on whether to support this document. The ACHDNC members will also consider a report on Quality Measures in Newborn Screening from the Follow up and Treatment Workgroup. HRSA will post the agenda two days prior to the meeting on the Committee’s website: https:// www.hrsa.gov/advisory-committees/ heritable-disorders/. Please note that agenda items are subject to changes as priorities dictate. Thursday, February 8, 2018, from 8:30 a.m. to 3:00 p.m. ET (meeting time is tentative). DATES: The address for the meeting is 5600 Fishers Lane, 5th Floor Pavilion, Rockville, MD 20857. Participants may also access the meeting through Webcast. Advanced registration is required. Please register online at https:// www.achdncmeetings.org/ by 12:00 p.m. ET on February 5, 2018. Instructions on how to access the meeting via Webcast will be provided upon registration. Please note that the 5600 Fishers Lane building requires security screening on entry. Visitors must provide a driver’s license, passport, or other form of government-issued photo identification or they cannot enter the facility. Per the original meeting notice, non-US Citizens planning to attend in person had to provide additional information to HRSA by January 24, 2018, 12:00 p.m. Eastern Time. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACHDNC should contact Ann Ferrero, Maternal and Child Health Bureau (MCHB), HRSA, in one of three ways: (1) Send a request to the following address: Ann Ferrero, MCHB, HRSA 5600 Fishers Lane, Room 18N100C, Rockville, MD 20857; (2) call 301–443– 3999; or (3) send an email to: AFerrero@ hrsa.gov. Correction: Date and time of the ACHDNC’s public meeting. The meeting PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 5265 will now be held on Thursday, February 8, 2018, from 8:30 a.m. to 3:00 p.m. ET. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–02306 Filed 2–5–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Minority Health and Health Disparities; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel; Special Emphasis Panel (R13) Conferences Grants. Date: March 16, 2018. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health NIMHD, 7201 Wisconsin Ave., Suite 533, Bethesda, MD 20814. Contact Person: Richard C. Palmer, DRPH, Health Scientist Administrator, National Institute on Minority Health and Health Disparities, National Institutes of Health, 7201 Wisconsin Ave, Bethesda, MD 20814, (301) 451–2432, richard.palmer@nih.gov. Dated: January 31, 2018. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–02279 Filed 2–5–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as E:\FR\FM\06FEN1.SGM 06FEN1

Agencies

[Federal Register Volume 83, Number 25 (Tuesday, February 6, 2018)]
[Notices]
[Page 5265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02306]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


Advisory Committee on Heritable Disorders in Newborns and 
Children

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: This notice announces a correction to the meeting announcement 
for a public meeting of the Advisory Committee on Heritable Disorders 
in Newborns and Children (ACHDNC), published in the Federal Register on 
January 22, 2018. The meeting has changed from a two-day meeting to a 
one-day meeting, to be held on Thursday, February 8, 2018. Agenda items 
have been updated and will include a final evidence-based review report 
on the spinal muscular atrophy (SMA) condition nomination for possible 
inclusion on the Recommended Uniform Screening Panel (RUSP). Following 
this report, the ACHDNC expects to vote on whether to recommend adding 
SMA to the RUSP to the Secretary of HHS. The agenda will also include 
presentation of a document on cutoff determinations and risk assessment 
methods used for dried bloodspot newborn screening. The Committee 
expects to vote on whether to support this document. The ACHDNC members 
will also consider a report on Quality Measures in Newborn Screening 
from the Follow up and Treatment Workgroup. HRSA will post the agenda 
two days prior to the meeting on the Committee's website: https://www.hrsa.gov/advisory-committees/heritable-disorders/. Please 
note that agenda items are subject to changes as priorities dictate.

DATES: Thursday, February 8, 2018, from 8:30 a.m. to 3:00 p.m. ET 
(meeting time is tentative).

ADDRESSES: The address for the meeting is 5600 Fishers Lane, 5th Floor 
Pavilion, Rockville, MD 20857. Participants may also access the meeting 
through Webcast. Advanced registration is required. Please register 
online at https://www.achdncmeetings.org/ by 12:00 p.m. ET on February 
5, 2018. Instructions on how to access the meeting via Webcast will be 
provided upon registration.
    Please note that the 5600 Fishers Lane building requires security 
screening on entry. Visitors must provide a driver's license, passport, 
or other form of government-issued photo identification or they cannot 
enter the facility. Per the original meeting notice, non-US Citizens 
planning to attend in person had to provide additional information to 
HRSA by January 24, 2018, 12:00 p.m. Eastern Time.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the ACHDNC should contact Ann Ferrero, Maternal and Child 
Health Bureau (MCHB), HRSA, in one of three ways: (1) Send a request to 
the following address: Ann Ferrero, MCHB, HRSA 5600 Fishers Lane, Room 
18N100C, Rockville, MD 20857; (2) call 301-443-3999; or (3) send an 
email to: [email protected].
    Correction: Date and time of the ACHDNC's public meeting. The 
meeting will now be held on Thursday, February 8, 2018, from 8:30 a.m. 
to 3:00 p.m. ET.

Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-02306 Filed 2-5-18; 8:45 am]
 BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.